Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 121

1.

PP2A-Bgamma subunit and KCNQ2 K+ channels in bipolar disorder.

Borsotto M, Cavarec L, Bouillot M, Romey G, Macciardi F, Delaye A, Nasroune M, Bastucci M, Sambucy JL, Luan JJ, Charpagne A, Jouët V, Léger R, Lazdunski M, Cohen D, Chumakov I.

Pharmacogenomics J. 2007 Apr;7(2):123-32. Epub 2006 May 30.

PMID:
16733521
2.

TREK-1, a K+ channel involved in polymodal pain perception.

Alloui A, Zimmermann K, Mamet J, Duprat F, Noël J, Chemin J, Guy N, Blondeau N, Voilley N, Rubat-Coudert C, Borsotto M, Romey G, Heurteaux C, Reeh P, Eschalier A, Lazdunski M.

EMBO J. 2006 Jun 7;25(11):2368-76. Epub 2006 May 4.

3.

Effects of a mosquitocidal toxin on a mammalian epithelial cell line expressing its target receptor.

Pauchet Y, Luton F, Castella C, Charles JF, Romey G, Pauron D.

Cell Microbiol. 2005 Sep;7(9):1335-44.

PMID:
16098220
4.

TREK-1, a K+ channel involved in neuroprotection and general anesthesia.

Heurteaux C, Guy N, Laigle C, Blondeau N, Duprat F, Mazzuca M, Lang-Lazdunski L, Widmann C, Zanzouri M, Romey G, Lazdunski M.

EMBO J. 2004 Jul 7;23(13):2684-95. Epub 2004 Jun 3.

5.

Focal adhesion kinase pp125FAK interacts with the large conductance calcium-activated hSlo potassium channel in human osteoblasts: potential role in mechanotransduction.

Rezzonico R, Cayatte C, Bourget-Ponzio I, Romey G, Belhacene N, Loubat A, Rocchi S, Van Obberghen E, Girault JA, Rossi B, Schmid-Antomarchi H.

J Bone Miner Res. 2003 Oct;18(10):1863-71.

6.

Mechanisms underlying excitatory effects of group I metabotropic glutamate receptors via inhibition of 2P domain K+ channels.

Chemin J, Girard C, Duprat F, Lesage F, Romey G, Lazdunski M.

EMBO J. 2003 Oct 15;22(20):5403-11.

7.

p11, an annexin II subunit, an auxiliary protein associated with the background K+ channel, TASK-1.

Girard C, Tinel N, Terrenoire C, Romey G, Lazdunski M, Borsotto M.

EMBO J. 2002 Sep 2;21(17):4439-48.

8.

Mice display sex differences in halothane-induced polymorphic ventricular tachycardia.

Drici MD, Baker L, Plan P, Barhanin J, Romey G, Salama G.

Circulation. 2002 Jul 23;106(4):497-503.

PMID:
12135952
9.

Prostaglandin E2 induces interaction between hSlo potassium channel and Syk tyrosine kinase in osteosarcoma cells.

Rezzonico R, Schmid-Alliana A, Romey G, Bourget-Ponzio I, Breuil V, Breittmayer V, Tartare-Deckert S, Rossi B, Schmid-Antomarchi H.

J Bone Miner Res. 2002 May;17(5):869-78.

10.

A TREK-1-like potassium channel in atrial cells inhibited by beta-adrenergic stimulation and activated by volatile anesthetics.

Terrenoire C, Lauritzen I, Lesage F, Romey G, Lazdunski M.

Circ Res. 2001 Aug 17;89(4):336-42.

PMID:
11509450
11.

Genomic and functional characteristics of novel human pancreatic 2P domain K(+) channels.

Girard C, Duprat F, Terrenoire C, Tinel N, Fosset M, Romey G, Lazdunski M, Lesage F.

Biochem Biophys Res Commun. 2001 Mar 23;282(1):249-56.

PMID:
11263999
12.

The bee venom peptide tertiapin underlines the role of I(KACh) in acetylcholine-induced atrioventricular blocks.

Drici MD, Diochot S, Terrenoire C, Romey G, Lazdunski M.

Br J Pharmacol. 2000 Oct;131(3):569-77.

14.

Effects of calcium channel blockers on cloned cardiac K+ channels IKr and IKs.

Chouabe C, Drici MD, Romey G, Barhanin J.

Therapie. 2000 Jan-Feb;55(1):195-202.

PMID:
10860024
15.

The neuroprotective agent riluzole activates the two P domain K(+) channels TREK-1 and TRAAK.

Duprat F, Lesage F, Patel AJ, Fink M, Romey G, Lazdunski M.

Mol Pharmacol. 2000 May;57(5):906-12.

PMID:
10779373
16.

Polyunsaturated fatty acids are potent neuroprotectors.

Lauritzen I, Blondeau N, Heurteaux C, Widmann C, Romey G, Lazdunski M.

EMBO J. 2000 Apr 17;19(8):1784-93.

17.

Novel mutations in KvLQT1 that affect Iks activation through interactions with Isk.

Chouabe C, Neyroud N, Richard P, Denjoy I, Hainque B, Romey G, Drici MD, Guicheney P, Barhanin J.

Cardiovasc Res. 2000 Mar;45(4):971-80.

PMID:
10728423
18.

Inhalational anesthetics activate two-pore-domain background K+ channels.

Patel AJ, Honoré E, Lesage F, Fink M, Romey G, Lazdunski M.

Nat Neurosci. 1999 May;2(5):422-6.

PMID:
10321245
19.

Cloning of a new mouse two-P domain channel subunit and a human homologue with a unique pore structure.

Salinas M, Reyes R, Lesage F, Fosset M, Heurteaux C, Romey G, Lazdunski M.

J Biol Chem. 1999 Apr 23;274(17):11751-60.

20.

HERG and KvLQT1/IsK, the cardiac K+ channels involved in long QT syndromes, are targets for calcium channel blockers.

Chouabe C, Drici MD, Romey G, Barhanin J, Lazdunski M.

Mol Pharmacol. 1998 Oct;54(4):695-703.

PMID:
9765513
21.

Involvement of IsK-associated K+ channel in heart rate control of repolarization in a murine engineered model of Jervell and Lange-Nielsen syndrome.

Drici MD, Arrighi I, Chouabe C, Mann JR, Lazdunski M, Romey G, Barhanin J.

Circ Res. 1998 Jul 13;83(1):95-102.

PMID:
9670922
22.

Deexcitation of cardiac cells.

Pumir A, Romey G, Krinsky V.

Biophys J. 1998 Jun;74(6):2850-61.

23.

Extracellular ATP and UTP control the generation of reactive oxygen intermediates in human macrophages through the opening of a charybdotoxin-sensitive Ca2+-dependent K+ channel.

Schmid-Antomarchi H, Schmid-Alliana A, Romey G, Ventura MA, Breittmayer V, Millet MA, Husson H, Moghrabi B, Lazdunski M, Rossi B.

J Immunol. 1997 Dec 15;159(12):6209-15.

PMID:
9550424
24.

Properties of KvLQT1 K+ channel mutations in Romano-Ward and Jervell and Lange-Nielsen inherited cardiac arrhythmias.

Chouabe C, Neyroud N, Guicheney P, Lazdunski M, Romey G, Barhanin J.

EMBO J. 1997 Sep 1;16(17):5472-9.

25.

Molecular mechanism and functional significance of the MinK control of the KvLQT1 channel activity.

Romey G, Attali B, Chouabe C, Abitbol I, Guillemare E, Barhanin J, Lazdunski M.

J Biol Chem. 1997 Jul 4;272(27):16713-6.

26.

Cloning, functional expression and brain localization of a novel unconventional outward rectifier K+ channel.

Fink M, Duprat F, Lesage F, Reyes R, Romey G, Heurteaux C, Lazdunski M.

EMBO J. 1996 Dec 16;15(24):6854-62.

27.

K(V)LQT1 and lsK (minK) proteins associate to form the I(Ks) cardiac potassium current.

Barhanin J, Lesage F, Guillemare E, Fink M, Lazdunski M, Romey G.

Nature. 1996 Nov 7;384(6604):78-80.

PMID:
8900282
28.

A new K+ channel beta subunit to specifically enhance Kv2.2 (CDRK) expression.

Fink M, Duprat F, Lesage F, Heurteaux C, Romey G, Barhanin J, Lazdunski M.

J Biol Chem. 1996 Oct 18;271(42):26341-8.

29.

Involvement of the dihydropyridine receptor and internal Ca2+ stores in myoblast fusion.

Seigneurin-Venin S, Parrish E, Marty I, Rieger F, Romey G, Villaz M, Garcia L.

Exp Cell Res. 1996 Mar 15;223(2):301-7.

PMID:
8601407
30.

TWIK-1, a ubiquitous human weakly inward rectifying K+ channel with a novel structure.

Lesage F, Guillemare E, Fink M, Duprat F, Lazdunski M, Romey G, Barhanin J.

EMBO J. 1996 Mar 1;15(5):1004-11.

31.

A pH-sensitive yeast outward rectifier K+ channel with two pore domains and novel gating properties.

Lesage F, Guillemare E, Fink M, Duprat F, Lazdunski M, Romey G, Barhanin J.

J Biol Chem. 1996 Feb 23;271(8):4183-7.

32.

Dominant negative chimeras provide evidence for homo and heteromultimeric assembly of inward rectifier K+ channel proteins via their N-terminal end.

Fink M, Duprat F, Heurteaux C, Lesage F, Romey G, Barhanin J, Lazdunski M.

FEBS Lett. 1996 Jan 2;378(1):64-8.

33.

Susceptibility of cloned K+ channels to reactive oxygen species.

Duprat F, Guillemare E, Romey G, Fink M, Lesage F, Lazdunski M, Honore E.

Proc Natl Acad Sci U S A. 1995 Dec 5;92(25):11796-800.

34.

Molecular properties of neuronal G-protein-activated inwardly rectifying K+ channels.

Lesage F, Guillemare E, Fink M, Duprat F, Heurteaux C, Fosset M, Romey G, Barhanin J, Lazdunski M.

J Biol Chem. 1995 Dec 1;270(48):28660-7.

35.

Heterologous multimeric assembly is essential for K+ channel activity of neuronal and cardiac G-protein-activated inward rectifiers.

Duprat F, Lesage F, Guillemare E, Fink M, Hugnot JP, Bigay J, Lazdunski M, Romey G, Barhanin J.

Biochem Biophys Res Commun. 1995 Jul 17;212(2):657-63.

PMID:
7626080
36.
37.
39.

Molecular cloning of a murine N-type calcium channel alpha 1 subunit. Evidence for isoforms, brain distribution, and chromosomal localization.

Coppola T, Waldmann R, Borsotto M, Heurteaux C, Romey G, Mattéi MG, Lazdunski M.

FEBS Lett. 1994 Jan 24;338(1):1-5.

40.

Molecular biology of voltage-gated K+ channels in heart.

Honoré E, Lesage F, Romey G.

Fundam Clin Pharmacol. 1994;8(2):108-16. Review.

PMID:
8020869
41.

The protein IsK is a dual activator of K+ and Cl- channels.

Attali B, Guillemare E, Lesage F, Honoré E, Romey G, Lazdunski M, Barhanin J.

Nature. 1993 Oct 28;365(6449):850-2.

PMID:
8413671
42.

Are Xenopus oocytes unique in displaying functional IsK channel heterologous expression?

Lesage F, Attali B, Lakey J, Honoré E, Romey G, Faurobert E, Lazdunski M, Barhanin J.

Receptors Channels. 1993;1(2):143-52.

PMID:
8081718
43.
44.

Adriamycin promotes neurite outgrowth in the "neurite-minus" N1A-103 mouse neuroblastoma cell line.

Larcher JC, Cordeau-Lossouarn L, Romey G, Gros F, Croizat B, Vayssiere JL.

Exp Cell Res. 1992 Nov;203(1):72-9.

PMID:
1330660
45.

Different types of K+ channel current are generated by different levels of a single mRNA.

Honoré E, Attali B, Romey G, Lesage F, Barhanin J, Lazdunski M.

EMBO J. 1992 Jul;11(7):2465-71.

46.

Cloning, functional expression, and regulation of two K+ channels in human T lymphocytes.

Attali B, Romey G, Honoré E, Schmid-Alliana A, Mattéi MG, Lesage F, Ricard P, Barhanin J, Lazdunski M.

J Biol Chem. 1992 Apr 25;267(12):8650-7.

48.

Conditional immortalization of normal and dysgenic mouse muscle cells by the SV40 large T antigen under the vimentin promoter control.

Pinçon-Raymond M, Vicart P, Bois P, Chassande O, Romey G, Varadi G, Li ZL, Lazdunski M, Rieger F, Paulin D.

Dev Biol. 1991 Dec;148(2):517-28.

PMID:
1660419
49.

Cloning, expression, pharmacology and regulation of a delayed rectifier K+ channel in mouse heart.

Honoré E, Attali B, Romey G, Heurteaux C, Ricard P, Lesage F, Lazdunski M, Barhanin J.

EMBO J. 1991 Oct;10(10):2805-11.

50.

Induction of normal ultrastructure by CGRP treatment in dysgenic myotubes.

Garcia L, Pinçon-Raymond M, Romey G, Changeux JP, Lazdunski M, Rieger F.

FEBS Lett. 1990 Apr 9;263(1):147-52.

Supplemental Content

Support Center